SCHEMBL8696239

SCHEMBL8696239

O=S(=O)(Oc1ccccc1)c1cccc(OCC2CCCNC2)c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 2/20 0.43
CHUK O15111 2/20 0.43
PIM1 P11309 2/20 0.41
PIM2 Q9P1W9 2/20 0.41
F2 P00734 3/20 0.39
CHRNB2 P17787 2/20 0.39
CHRNA4 P43681 2/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
SCN9A Q15858 1/20 0.39
HTR6 P50406 2/20 0.38
MAP2K1 Q02750 1/20 0.38
EED O75530 1/20 0.38
SLC6A2 P23975 3/20 0.37
SLC6A4 P31645 3/20 0.37
SLC6A3 Q01959 2/20 0.37
KMT2A Q03164 1/20 0.37
HPGD P15428 1/20 0.36
CYP2D6 P10635 1/20 0.36
KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8695545 0.87 HTR6 (0.45) IKBKBCHUKF2HTR6SLC6A2
SCHEMBL7445929 0.81 F2 (0.60) IKBKBCHUKF2HTR6MAP2K1
SCHEMBL7442091 0.75 F2 (0.66) F2CTRC
SCHEMBL3325725 0.75 IKBKB (0.53) IKBKBCHUKPIM1PIM2CHRNB2
SCHEMBL3325732 0.75 IKBKB (0.53) IKBKBCHUKPIM1PIM2CHRNB2
SCHEMBL3444195 0.74 SLC6A2 (0.57) IKBKBCHUKCHRNB2CHRNA4CHRNB4
SCHEMBL2267290 0.74 SLC6A2 (0.57) IKBKBCHUKCHRNB2CHRNA4CHRNB4
SCHEMBL8695784 0.74 HTR6 (0.52) PIM1PIM2F2HTR6SLC6A2
Hydrochloric Acid SCHEMBL3325199 0.74 IKBKB (0.52) IKBKBCHUKPIM1PIM2CHRNB2
Hydrochloric Acid SCHEMBL3325203 0.74 IKBKB (0.52) IKBKBCHUKPIM1PIM2CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5792769-A POTENT ANTICOAGULANT, ANTIINFLAMMATORY AGENT; TREATMENT/PROPHYLAXIS OF RESPIRATORY SYSTEM DISORDERS, VASCULAR SYSTEM DISORDERS, ANTITUMOR AGENTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1998-08-11 US disclosed